Altered glycosylation of proteins in cancer: what is the potential for new anti-tumour strategies.
about
Turning-Off Signaling by Siglecs, Selectins, and Galectins: Chemical Inhibition of Glycan-Dependent Interactions in CancerGlycosylation of matrix metalloproteases and tissue inhibitors: present state, challenges and opportunitiesThe Sweet Side of Immune Evasion: Role of Glycans in the Mechanisms of Cancer ProgressionMolecular simulations of carbohydrates and protein-carbohydrate interactions: motivation, issues and prospectsGlycoproteins and glycoproteomics in pancreatic cancerPharmacological inhibition of polysialyltransferase ST8SiaII modulates tumour cell migrationImaging the glycome in living systemsAdvancement of Sialyltransferase Inhibitors: Therapeutic Challenges and OpportunitiesQuantitative glycoproteomics analysis reveals changes in N-glycosylation level associated with pancreatic ductal adenocarcinoma.Characterization of kallikrein-related peptidase 4 glycosylationsQuantifying proteins by mass spectrometry: the selectivity of SRM is only part of the problemIncreased sialylation of anti-Thomsen-Friedenreich antigen (CD176) antibodies in patients with gastric cancer: a diagnostic and prognostic potentialMass spectrometry based glycoproteomics--from a proteomics perspectiveProtein analysis by shotgun/bottom-up proteomicsMacroporous cryogel based spin column with immobilized concanavalin A for isolation of glycoproteins.Protein glycosylation in cancer.Human beta-galactoside alpha-2,3-sialyltransferase (ST3Gal III) attenuated Taxol-induced apoptosis in ovarian cancer cells by downregulating caspase-8 activity.Revealing Glycoproteins in the Secretome of MCF-7 Human Breast Cancer Cells.Proteomics analysis of bodily fluids in pancreatic cancerSpectral library-based glycopeptide analysis-detection of circulating galectin-3 binding protein in pancreatic cancer.Glycoprotein disease markers and single protein-omicsClustered carbohydrates in synthetic vaccines.Mammalian glycosylation in immunity.VHL-dependent regulation of a β-dystroglycan glycoform and glycogene expression in renal cancerA newly generated functional antibody identifies Tn antigen as a novel determinant in the cancer cell-lymphatic endothelium interactionImmunotherapy for cancer: synthetic carbohydrate-based vaccines.Discovering potential serological biomarker for chronic Hepatitis B Virus-related hepatocellular carcinoma in Chinese population by MAL-associated serum glycoproteomics analysis.LW-AFC Effects on N-glycan Profile in Senescence-Accelerated Mouse Prone 8 Strain, a Mouse Model of Alzheimer's Disease.Cell-based models to test the effects of milk-derived bioactives.Advances in membrane proteomics and cancer biomarker discovery: current status and future perspective.Glycocapture-based proteomics for secretome analysis.The sweets standing at the borderline between allo- and xenotransplantation.LC-MS/MS in the routine clinical laboratory: has its time come?Lectin Histochemistry for Metastasizing and Non-metastasizing Cancer Cells.Quantification of tunicamycin-induced protein expression and N-glycosylation changes in yeast.Lectin Histochemistry: Historical Perspectives, State of the Art, and the Future.Glycans in melanoma screening. Part 2. Towards the understanding of integrin N-glycosylation in melanoma.Requirement for a core 1 galactosyltransferase in the Drosophila nervous system.Applying pose clustering and MD simulations to eliminate false positives in molecular docking.Immunoglobulin G Fc N-glycan profiling in patients with gastric cancer by LC-ESI-MS: relation to tumor progression and survival.
P2860
Q26744538-97718CCA-52D8-4B7D-9ED3-FA3A5B6733AEQ26745510-B2AAB635-96F8-415D-8C06-77186A268C67Q26750877-BADB6E14-452E-4EF5-A1BD-5D07656F66E0Q27686945-99D3E1EB-DE9C-4D34-9367-0D810286F828Q28071108-FF5AFEBE-D3C3-41D4-B41D-EE4CC31E5174Q28535224-28AE5B4E-6676-48F9-9FFE-6B87125CC281Q28831095-B348CACE-10DA-4B79-B8EC-DB612B66D6BAQ30039640-DBFA02D7-87FC-496D-9169-7B49D8BE9C3FQ30576595-CA663801-FD3E-41F4-B2D2-D0BF2E5FCA9DQ34127176-92765122-8645-4D95-B3BE-4E07A307CB72Q34200023-EDA41448-C882-4D79-B1B6-F2A92CCEA38DQ34208137-D8745DE5-15BB-4D6E-8A37-547F1D992DCCQ34454989-9353AB2E-E6AB-4446-9324-6197C85B6FA4Q34600986-B6FBB2C5-A160-4ADA-AB93-D5B9DE61A998Q35313626-2649A8F7-D87A-4F85-B01D-4114C290F9CCQ35413473-3C88A2D5-1910-467B-9768-50D5E32D285BQ35668911-408F845A-2B06-4A0C-BE94-6B879B1FD183Q35807042-F73D2CBE-2653-493B-ABAC-6520D44558B4Q35920900-B9CD45D4-C2F3-4BA1-9F2C-AF3BC984D5A5Q36408948-14C0ED37-8D26-4475-8303-26CEFB7BDAB0Q36742398-2F145D84-CD38-476B-A6F2-8E78351044F6Q36844110-550563B2-5430-4E16-9B50-496FA6152F10Q37290930-4E6F1EC2-7705-46FB-85B0-E976393B7F05Q37296108-ABD180FB-0393-49BB-9785-DAC17C83E874Q37328722-42C8EBE9-AA93-4341-AB5D-4A462B99CA02Q37453814-B446F5C2-779D-4456-8D9C-18113E2FE012Q37581704-95CEF464-D805-470F-8D4B-D501B82291C9Q37619203-E1EB6EF8-DCAA-4DC6-964A-D054B11C8B14Q37995773-F9A83120-862A-4932-B814-A929280C406AQ38034447-0FF94E60-36A4-4C10-B2DB-6096E3438BEEQ38063829-8F06CD25-5E50-4CC8-AF7E-60B7866618B0Q38095674-25D3E165-C4DC-460F-B1A8-26F5D65C5036Q38171274-21DF85DF-5033-4A5B-AE0F-DDC7017F4B16Q38289185-83B02E35-97A1-4FAD-9AB8-4980AA2935F0Q38449518-EBA1A785-CE02-41DE-ADED-D9FF3F47C8E5Q38762354-CCCCABC6-B1C6-42EA-9C8F-2D2DEF5893BAQ39789994-4D7FD971-A66D-4CB8-ACBF-AE9AAE8A32B7Q43076807-FFA4F751-C82F-4435-8DCD-2DF6BEAEB443Q50067648-603D09F1-6A44-44C5-8ABB-8804860333FEQ55055409-B6189D91-A02F-4505-9697-24F16229E3AE
P2860
Altered glycosylation of proteins in cancer: what is the potential for new anti-tumour strategies.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Altered glycosylation of prote ...... or new anti-tumour strategies.
@en
Altered glycosylation of prote ...... or new anti-tumour strategies.
@nl
type
label
Altered glycosylation of prote ...... or new anti-tumour strategies.
@en
Altered glycosylation of prote ...... or new anti-tumour strategies.
@nl
prefLabel
Altered glycosylation of prote ...... or new anti-tumour strategies.
@en
Altered glycosylation of prote ...... or new anti-tumour strategies.
@nl
P2093
P1476
Altered glycosylation of prote ...... or new anti-tumour strategies.
@en
P2093
P356
10.2174/187152008783330860
P577
2008-01-01T00:00:00Z